Researchers at the Indian Institute of Technology (IIT) Guwahati have made a significant breakthrough in understanding the African Swine Fever Virus (ASFV), focusing on the p30 protein’s role in the virus’s infection process. This discovery could pave the way for new strategies to combat swine fever, a devastating disease affecting pigs.
Led by Professor Sachin Kumar, along with research scholars Satyendu Nandy, Nilave Ranjan Bora, and Shubham Gaurav, the team has delved into the biochemistry of ASFV, particularly examining the protein components found in the virus’s outer membrane. The p30 protein is crucial in the virus’s ability to attach to host cells. It binds to specific receptors on cell surfaces, facilitating the fusion of viral and cell membranes, which is essential for the virus’s entry into the host.
The team’s research, recently published in the esteemed journal Virology, highlights the p30 protein’s role beyond mere attachment. They discovered that p30 possesses RNase-like activity, meaning it can degrade RNA. This enzymatic function is rare among viruses but vital for ASFV. By breaking down the host’s RNA, the virus can evade the immune system, a crucial factor in its persistence and spread.
Professor Sachin Kumar commented on the research, stating, “Our study into ASFV aims to reveal the functional roles of proteins like p30, which are integral to the virus’s ability to infect and evade the host’s immune response.” The research builds upon previous findings where the team identified epitopic domains on p30 that could activate the immune system. These domains are significant for developing potential vaccines and treatments.
The team utilized techniques such as electrophoresis and fluorimetry to analyze p30’s RNase activity. They observed that the protein’s ability to degrade RNA is dependent on its concentration and the exposure duration. Notably, the researchers found that altering the amino acid composition of p30 affects its RNA-degrading activity, providing insights into the protein’s function.
The discovery of p30’s RNase activity is crucial in understanding how ASFV manipulates host cell functions. By degrading RNA, the p30 protein may alter cellular processes, aiding the virus’s survival and replication. This understanding could lead to novel therapeutic approaches targeting these viral mechanisms.
While the findings are promising, Professor Kumar acknowledged that further research is needed. Key questions remain about the specific role of p30 in ASFV infection in pigs and whether its RNase activity targets particular host RNA molecules. The research team plans to address these questions in future studies.
This breakthrough follows the recent technology transfer by the research group to develop the first recombinant vaccine for swine fever, marking a significant step forward in controlling ASFV. The continued investigation into ASFV’s biochemistry and p30 protein’s role could ultimately lead to more effective treatments and preventive measures against this devastating disease.
